Anti-coagulant
Citra-Lock™ Anti-coagulant
Citra-lock™ causes anticoagulation by chelation of ionised calcium in the extracorpereal circuit into a soluble complex. Because calcium is an integralion involved in the clotting cascade, local removal by Citra-Lock™ prevents the activation of clotting factors, factor X, and prothrombin, and the ultimate formation of fibrin. Systematic anticoalgulation does not occur.
This figure shows a 4 month period with a zero use of Urokinase (thrombolytic agent), proving that tri sodium citrate 46,7% (Citra-Lock™) prevents the catheter related thrombosis 1.
1. Ash SR (2000) Concentrated Sodium Citrate (23%) for Catheter Lock. Haemodialysis International 4:22-31
Newsletter
Subscribe to our newsletter!Please fill out the form below so we can inform when there are:
- New scientific articles with Citra-Lock™
- Exhibition & Congress dates
- New product release information
- Latest updates about Citra-lock™ guidelines
Signout from our newsletter




